In Vitro models of Infections: the postantibiotic and sub-MIC effects in vitro and in vivo Inga Odenholt, MD., Ph.D. Department of Infectious Diseases.

Slides:



Advertisements
Similar presentations
All the following are antibiotics used for gram –ve bacteria.
Advertisements

A 23 Variability in the Size of the Fluoroquinolone AUC/MIC for Antibacterial Effect in S.aureus: Impact for Clinical Breakpoints A. R. Noel, K.E. Bowker,
Modifiers of Cell Survival: Repair
ANTIBIOTIC By:Afnan Bakhsh. Sir Alexander Fleming (1881 –1955)  “One sometimes finds what one is not  looking for“ Penicillin He observed inhibition.
Animal Model PK/PD: A Tool for Drug Development
Population PK/PD analysis of the bactericidal activity of sutezolid and its major metabolite against intracellular Mtb in whole blood cultures of TB patients.
Eccmid 2003 Aminoglycosiden bij neonaten Canisius-Wilhelmina Hospital Nijmegen, The Netherlands Johan W Mouton Relationship between bacterial killing,
Screening for new antibiotics
Plasmids Chromosome Plasmid Plasmid + Transposon Plasmid + integron Plasmid+transposon +intergron Chromosome Chromosome + transposon Chromosome + transposon.
PHL 424 Antimicrobials 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
PHL 521 Clinical Dental Therapeutics 1 st Lecture By Abdelkader Ashour, Ph.D. Phone:
APPLICATION OF MICROTESTER FOR DETECTION OF LOW MICROBIAL CONTAMINATION Oliver Reichart Katalin Szakmár.
Antibiotics Biotechnology II. Univ S. Carolina Antibiotics Disrupt Cell Wall Synthesis, Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
ANTIMICROBIAL RESISTANCE Edith Blondel-Hill MD,FRCP Medical Microbiologist/Infectious Diseases Specialist Medical Director Interior Health Antimicrobial.
Chapter 10: Restricting antibiotic use and optimizing dosing.
Pharmacodynamics of Antibiotics
Antibiotics Bio February 2010 Ethan Richman Ben Kwak Ampicillin, Tetracyclin, and Chloramphenicol.
Control of microbial growth. Antimicrobial Classes Disinfectants –Products aimed at reducing by at least five powers of 10 (99,999 %) the number of microorganisms/virus.
Microbiology Antimicrobial Susceptibility Testing – Part I Karen Honeycutt, M.Ed., MT(ASCP)SM CLS 418 Clinical Microbiology Student Laboratory Session.
Sub-MIC effects in vitro and in vivo Inga Odenholt, MD., Ph.D. Department of Infectious Diseases University hospital Malmö Sweden.
Office of Clinical Pharmacology and Biopharmaceutics IDSA/ISAP/FDA Workshop 4/16/04 In Vitro/Animal Models to Support Dosage Selection: FDA Perspective.
Carbapenem Activity Against Acinetobacter calcoaceticus-baumanii complex (ACBC) in an In Vitro Pharmacokinetic Bacteremia Model (PKM) Eric G Sahloff, Pharm.D.,
PK/PD of Antibiotics in relation to resistance Otto Cars MD Department of Medical Sciences Infectious diseases Uppsala University Sweden.
AMINOGLYCOSIDES The different members of this group share many properties in common. The different members of this group share many properties in common.
Mic 224 Lab 6 Streak Plate Technique and Antibiotic Sensitivity.
Application of PK/PD modeling for optimization of linezolid therapy Julia Zayezdnaya Zack.
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
Antigens Antibody Reaction. Complement Fixation Test.
General Principles of Antimicrobial Therapy. Concept #1: The guiding principle of antibiotic selection Antibiotic coverage should be kept to the narrowest.
Use of in vitro models to study the emergence of resistance Professor Inga Odenholt Department of Infectious Diseases University hospital, Malmö Sweden.
A Pharmacodynamic Model for Cefprozil against Haemphilus influenzae in an in vitro Infection Model across Multiple Regimens Olanrewaju O. Okusanya, Pharm.D,
CLINICAL PHARMACOLOGY OF ANTIBACTERIAL AGENTS. Actions of antibacterial drugs on bacterial cells.
Pharmacokinetics of Antimicrobials in Animals: Lessons Learned William A. Craig, M.D. University of Wisconsin-Madison.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 86 Aminoglycosides: Bactericidal Inhibitors of Protein Synthesis.
Introduction to antimicrobial agents. Definition: Use of drugs to combat infectious diseases and cancer. Antimicrobial drug ( 抗微生物药 ) Antiparasitic drug(
Methods for detecting resistance Goal: To determine whether organism expresses resistances to agents potentially used for therapy Designed to determine.
Animal Models in Early Evaluation of Antibacterial Agents
Pharmacodynamics of Antimicrobials in Animal Models William A. Craig, M.D. University of Wisconsin-Madison.
Prediction and Prevention of Emergence of Resistance of Clinically Used Antibacterials Fernando Baquero Dpt. Microbiology, Ramón y Cajal Hospìtal Madrid,
Antimicrobial drugs. Antimicrobial drugs are effective in the treatment of infections because of their selective toxicity (that is, they have the ability.
Antibiotic Resistance Emerging antibiotic resistance is a major health concern. 2 million people in the U.S. infected with antibiotic resistant bacteria.
IN THE NAME OF ALLAH ALMIGHTY THE MOST COMPASSIONATE THE MERCIFUL.
ANTIMICROBIALS Chapter 10.
Treatment Of Respiratory Tract infections. Prof. Azza ELMedany Department of Pharmacology Ext
Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern Qualitative Antimicrobial.
Pharmacodynamics of Antimicrobials William A. Craig, M.D. University of Wisconsin-Madison.
 Antimicrobial agents share certain common properties.  We can learn much about how these agents work and why they sometimes do not work by considering.
Treatment of Respiratory Tract infections. Prof. Azza EL-Medany.
Date of download: 6/28/2016 Copyright © 2016 American Society of Anesthesiologists. All rights reserved. Increased interleukin (IL)-10 release induced.
Antibiotics (anti-microbials)
PRINCIPLES OF ANTIBIOTIC THERAPY
Bacterial persistence
Protein Synthesis Inhibitors
Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring.
The aminoglycoside antibiotics
Background and objectives
Antimicrobial treatments and their mechanisms of action
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Margrét Valdimarsdóttir, Helga Erlendsdóttir, Sigurdur Gudmundsson 
Chemotherapeutic agent
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
P. Moreillon, J.M. Entenza  Clinical Microbiology and Infection 
Enhanced antimicrobial activity of peptide-cocktails against common bacterial contaminants of ex vivo stored platelets  K.V.K. Mohan, S. Sainath Rao,
Introduction to antibacterial drugs
ANTIMICROBIALS Chapter 10.
Department of Emergency Medicine Yonsei University Health System
In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae  Y. Harada,
Hadeel Kareem Musafer PhD
Principles of Antimicrobial Therapy
Presentation transcript:

In Vitro models of Infections: the postantibiotic and sub-MIC effects in vitro and in vivo Inga Odenholt, MD., Ph.D. Department of Infectious Diseases University hospital Malmö Sweden

Pharmacodynamic parameters Postantibiotic effect (PAE) –In vitro –In vivo Postfungal effect (PAFE) Postantibiotic sub-MIC effect (PA SME) –In vitro –In vivo

Post MIC effect (PME) Postantibiotic leucocyte enhancement (PALE) Sub-MIC effect (SME) Pharmacodynamic parameters

The postantibiotic effect in vitro

Postantibiotic effect; PAE in vitro Definition: Suppression of bacterial growth after short exposure of organisms to antibiotics PAE=T-C T= The time required for the exposed culture to increase one log 10 above the count observed immediately after drug removal C= The corresponding time for the unexposed control

Postantibiotic effect in vitro The PAE is dependent on: Type of antibiotic Type of bacterial species Concentration of the antibiotic Duration of exposure Size of the inoculum Growth phase of the organism

Antibioticshours Penicillins1-2 Cephalosporins1-2 Carbapenems1-2 Quinolones1-3 Proteinsythesis inhibitors3-5 PAE against Gram-positive bacteria

PAE against Gram-negative bacteria Antibioticshours Penicillins0 Cephalosporins0 Carbapenems(1) Quinolones1-3 Proteinsythesis inhibitors3-8 Aminoglycosides2-4

PAE against P. aeruginosa Antibioticshours Penicillins0 Cephalosporins0 Carbapenems1-2 Quinolones1-2 Aminoglycosides2-3

PAE in vitro Methods 1. Viable counts Methodological pitfalls may overestimate killing negative PAEs are common with ß-lactams and gram-negatives due to forming of filaments similar inocula of the control and the pre- exposed culture are desirable

PAE in vitro Methods 2.Optical density Methodological pitfalls killing cannot be measured due to a detection limit of 10 6 cfu/ml control curves at different inocula and viable counts after drug removal are necessary to be performed to ensure that PAE culture and control are at the same inoculum

PAE in vitro Methods 3.ATP measurement Methodological pitfalls bactericidal activity is underestimated due to dead but intact (not lysed) bacteria still containing intracellular ATP PAE is overestimated due to falsely elevated ATP content

PAE in vitro Methods 4.Morphology Phase contrast microscopy –the time it takes for the bacteria to revert to 90% bacilli 5. 3 H-thymidine incorporation Ultrastructural changes - the changes in structure correlates well with the PAE measured with viable counting - correlates well with the PAE measured with viable counting

The postantibiotic effect in vivo

Postantibiotic effect in vivo Definition PAE= T-C T= the time required for the counts of cfu in thighs of treated mice to increase one log 10 above the count closest to but not less than the time M C= the time required for the counts of cfu in thighs of untreated mice to increase one log 10 above the count at time zero M= the time serum concentration exceeds the MIC

PAE in vivo Observed in several animal models In vitro data are predictive of in vivo results except that in vivo PAE are usually longer due to the effect of sub-MICs and/or the effect of neutrophils The major unexplained discordant results are for ß-lactams and streptococci

Animal models PAE in vivo Animal models Thigh infections in mice Pneumonia model in mice Infected treads in mice Infected tissue cages in rabbits Meningitis model in rabbits Endocarditis model in rats

Mechanisms of PAE  -lactam antibiotics. At least for S. pyogenes and penicillin it has been shown that PAE stands for the time it takes for the bacteria to resynthesize new PBPs

Mechanisms of PAE Erythromycin and clarithromycin : 50S ribosomal subunits were reduced during 90 min and protein synthesis during 4 h (PAE) due to prolonged binding of the antibiotics to 50S.

Mechanisms of PAE Aminoglycosides: Binding of sublethal amounts of drug enough to disrupt DNA, RNA and protein synthesis. The time it takes to resynthesize these proteins. With a half-life of >2.5 h, the PAE disappears, reflecting a sufficient time for the repair mechanism to be restored.

Postfungal effect

PAFE assay Removal of the drug: 3 washes with saline solution and centrifugation for 10 minutes after each wash. Colony count determination: CFU of the exposed and control within same range. Incubation in a spectrophotometer reader at 37  C for 48 h. Growth: automatically monitored: OD changes at 10 minutes intervals.

Data analysis Three points in the growth curve of the controls and the exposure were analyzed: OD 0 : the time-point of the first significant increase in OD. OD 20 : the time-point where the OD reached 20% of the maximum of growth curve. OD 50 : the time-point where the OD reached 50% of the maximum of growth curve.

Results Mean and 95% confidencial interval of the ODx for the exposed and the corresponding controls of each species at each point in the growth curve are calculated. Presence of PAFE: Lower limit of the 95% CI of ODx of exposure > the upper limit of the 95% CI of the ODx of the corresponding control for each strain. PAFE OD 0 OD 20 Exposed Control OD 50 PAFE=T-C (  t) T: time of the exposed C: time of the control

PAFE of Amphotericin B A. fumigatus A. ustus A. terreus A. nidulans OD (3/3) 3.94 (2/3) 2.53 (2/3) N.P. (0/3) OD (3/3) N.P. (0/3) OD (3/3) 3.62 (1/3) 2.03 (2/3) N.P. (0/3) Significant PAFE: Lower 95% CI (exposed) >Upper 95% CI (control). N.P.: No PAFE A. fumigatus A. ustus A. terreus A. nidulans OD (3/3) 1.00 (2/3) 0.64 (1/3) 1.67 (1/3) OD (2/3) N.P. (0/3) 0.84 (1/3) N.P. (0/3) OD (1/3) N.P. (0/3) PAFE after 4h incubation with the drug at a concentration of 4 x MIC (Number of strains with presence of PAFE) 2.23 (2/3) PAFE after 2h incubation with the drug at a concentration of 4 x MIC

PAFE on different conditions PAFE: concentration and time dependent

PAFE for Itraconazole Incubation period: 4, 2 and 1h Drug concentrations: 50, 20, 10, 4, 1 and 0.25 times the MIC No PAFE was observed for all the strains

I. Conclusion The method developed seems to be useful to measure PAFE in moulds OD 0 was superior to OD 20 or OD 50 : –Least variation, reproducible –Shortest incubation period: economic –Maximum growth measurements not required

II. Conclusion For AMB: PAFE was dose and exposure time dependent No PAFE was observed after 1 h exposure at any concentration of AMB No PAFE was observed at 0.25 x MIC for AMB A. fumigatus displayed the longest PAFE For ITZ: No PAFE was present at any concentration and exposure period

The postantibiotic sub-MIC effect in vitro

Postantibiotic sub-MIC effect; PA SME Definition The effect of subinhibitory antibiotic concentrations on bacteria previously exposed to suprainhibitory concentrations PA SME= T PA -C T PA =the time it takes for the cultures previously exposed to antibiotics and thereafter to sub-MICs to increase by one log 10 above the counts observed immediately after washing. C=corresponding time for the unexposed control

The postantibiotic sub-MIC effect in vivo

PAE ( PASME) in vivo of amikacin against K. pneumoniae in a thigh-infection model in mice PAE Normal mice (half-life 19 min)5.5 h Uremic mice (half-life 98 min)14.6 h

Post-MIC effect (PME)

Post-MIC effect; PME Definition The effect of sub-MICs on bacteria previously exposed to a constant decreasing antibiotic concentration PME=Tpme-C Tpme= The time for the counts in cfu of the exposed culture to increase one log 10 above the count observed at the MIC level C= the time for an unexposed control to increase one log 10

Mechanism of PA SME? The PAE of ß-lactam antibiotics seems to represent the time necessary to synthesize new PBPs. When bacteria in the PA-phase are exposed to sub-MICs, most PBPs are still inactivated and only a small amount of the drug is needed to prolong the inhibition of cell multiplication until a critical number of free PBPs are once more available

Postantibiotic leucocyte enhancement

Postantibiotic leucocyte enhancement; PALE Bacteria pretreated with antibiotics for a brief period of time show increased susceptibility to intracellular killing and phagocytosis In general, antibiotics that produce the longest PAEs exhibit maximal PALEs

Sub-MIC effects

Sub-MIC effects; SME Definition The effect of subinhibitory antibiotic concentrations on bacteria not previously exposed to suprainhibitory concentrations SME= T s -C T s =the time it takes for the cultures exposed to sub-MICs to increase by one log 10 above the counts observed immediately after washing C=corresponding time for the unexposed control

Sub-MIC effects The minimum antibiotic concentrations that produces a structural change in bacteria seen by light or electron microscopy The minimum antibiotic concentration that produces a one log 10 decrease in the bacterial population compared to the control Loss or change of bacterial toxins

Sub-MIC effects Loss of surface antigens resulting in decreased adhesion Increased rates of phagocytic ingestion and killing Increased chemotaxsis and opsonization

Mechanism of sub-MIC effects SME probably tests the distribution of antibiotic susceptibility in the bacterial population, in which there are subpopulations that are inhibited by concentrations less than the MIC. The SME would therefore represent the time it takes for the population with the higher MIC to become dominant

Thank you very much for your attention

CONCLUSIONS Antibiotics that have long PAE / PASME or PME could maybe be dosed with longer intervals BUT : what about resistant subpopulations??